152 related articles for article (PubMed ID: 26729539)
1. A Case of a Central Conducting Lymphatic Anomaly Responsive to Sirolimus.
McCormick A; Rosenberg S; Trier K; Balest A
Pediatrics; 2016 Jan; 137(1):. PubMed ID: 26729539
[TBL] [Abstract][Full Text] [Related]
2. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
Ozeki M; Nozawa A; Yasue S; Endo S; Asada R; Hashimoto H; Fukao T
Orphanet J Rare Dis; 2019 Jun; 14(1):141. PubMed ID: 31196128
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease.
Ricci KW; Hammill AM; Mobberley-Schuman P; Nelson SC; Blatt J; Bender JLG; McCuaig CC; Synakiewicz A; Frieden IJ; Adams DM
Pediatr Blood Cancer; 2019 May; 66(5):e27614. PubMed ID: 30672136
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus in the Treatment of Vascular Anomalies.
Triana P; Dore M; Cerezo VN; Cervantes M; Sánchez AV; Ferrero MM; González MD; Lopez-Gutierrez JC
Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
[No Abstract] [Full Text] [Related]
5. Generalized lymphatic anomaly successfully treated with long-term, low-dose sirolimus.
Dvorakova V; Rea D; O'Regan GM; Irvine AD
Pediatr Dermatol; 2018 Jul; 35(4):533-534. PubMed ID: 29582448
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Lymphatic Malformations with the mTOR Inhibitor Sirolimus: A Systematic Review.
Wiegand S; Wichmann G; Dietz A
Lymphat Res Biol; 2018 Aug; 16(4):330-339. PubMed ID: 29924669
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus in the treatment of kaposiform lymphangiomatosis.
Zhou J; Yang K; Chen S; Ji Y
Orphanet J Rare Dis; 2021 Jun; 16(1):260. PubMed ID: 34103076
[TBL] [Abstract][Full Text] [Related]
8. Medical management of vascular anomalies.
Trenor CC
Semin Cutan Med Surg; 2016 Sep; 35(3):177-81. PubMed ID: 27607327
[TBL] [Abstract][Full Text] [Related]
9. Targeted treatment in complex lymphatic anomaly: a case of synergistic efficacy of trametinib and sirolimus.
Seront E; Froidure A; Revencu N; Dekeuleneer V; Clapuyt P; Dumitriu D; Vikkula M; Boon LM
Orphanet J Rare Dis; 2024 May; 19(1):199. PubMed ID: 38750525
[TBL] [Abstract][Full Text] [Related]
10. Rapid regression of lymphadenopathy upon rapamycin treatment in a child with autoimmune lymphoproliferative syndrome.
Janić MD; Brasanac CD; Janković JS; Dokmanović BL; Krstovski RN; Kraguljac Kurtović JN
Pediatr Blood Cancer; 2009 Dec; 53(6):1117-9. PubMed ID: 19588524
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of kaposiform lymphangiomatosis with sirolimus.
Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
Pediatr Blood Cancer; 2015 Jul; 62(7):1291-3. PubMed ID: 25598153
[TBL] [Abstract][Full Text] [Related]
12. Spinal cord arteriovenous malformation with an associated lymphatic anomaly. Case report.
Kraus GE; Bucholz RD; Weber TR
J Neurosurg; 1990 Nov; 73(5):768-73. PubMed ID: 2213167
[TBL] [Abstract][Full Text] [Related]
13. Indications and Limitations of Sirolimus in the Treatment of Vascular Anomalies-Insights From a Retrospective Case Series.
Karastaneva A; Gasparella P; Tschauner S; Crazzolara R; Kropshofer G; Modl M; Pfleger A; Burmas A; Pocivalnik M; Ulreich R; Zenz W; Schwinger W; Beqo BP; Urban C; Haxhija EQ; Lackner H; Benesch M
Front Pediatr; 2022; 10():857436. PubMed ID: 35676905
[TBL] [Abstract][Full Text] [Related]
14. Single-center experience with sirolimus therapy for vascular malformations.
Yesil S; Tanyildiz HG; Bozkurt C; Cakmakci E; Sahin G
Pediatr Hematol Oncol; 2016 Apr; 33(3):219-25. PubMed ID: 27128161
[TBL] [Abstract][Full Text] [Related]
15. The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children.
Mutalib M; Borrelli O; Blackstock S; Kiparissi F; Elawad M; Shah N; Lindley K
J Crohns Colitis; 2014 Dec; 8(12):1730-4. PubMed ID: 25240477
[TBL] [Abstract][Full Text] [Related]
16. CLAPO syndrome: Effective response to treatment with oral rapamycin.
González-Hermosa MR; Guerra E; Tuduri I; Vicente I; López-Almaraz R
Dermatol Ther; 2019 Jul; 32(4):e12991. PubMed ID: 31172613
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus for the Treatment of a Massive Capillary-Lymphatico-Venous Malformation: A Case Report.
Vlahovic AM; Vlahovic NS; Haxhija EQ
Pediatrics; 2015 Aug; 136(2):e513-6. PubMed ID: 26148957
[TBL] [Abstract][Full Text] [Related]
18. A neonatal case of central conducting lymphatic anomaly successfully treated with sirolimus.
Passarello L; Lau C; McCahon E; Popat H
Pediatr Blood Cancer; 2022 Dec; 69(12):e29752. PubMed ID: 35652569
[No Abstract] [Full Text] [Related]
19. Complex lymphatic anomalies.
Trenor CC; Chaudry G
Semin Pediatr Surg; 2014 Aug; 23(4):186-90. PubMed ID: 25241096
[TBL] [Abstract][Full Text] [Related]
20. Generalized Lymphatic Anomaly and Gorham-Stout Disease: Overview and Recent Insights.
Ozeki M; Fukao T
Adv Wound Care (New Rochelle); 2019 Jun; 8(6):230-245. PubMed ID: 31236308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
